What are the hepatic considerations or potential liver-related side effects when prescribing solifenacin?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18215217
Cited by: 0

Abstract

Solifenacin has specific hepatic considerations due to increased plasma levels in impaired liver function, especially contraindicated in severe impairment and limited to 5 mg in moderate impairment.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Drug-Induced Hepatotoxicity and Protection Urinary Bladder and Prostate Research

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 January 2026